Introduction: Under the U.S. national Alzheimer's plan, the National Institutes of Health identified milestones required to meet the plan's biomedical research goal (Goal 1). However, similar milestones have not been created for the goals on care (Goal 2) and support (Goal 3). Methods: The Alzheimer's Association convened a workgroup with expertise in clinical care, long-term services and supports, dementia care and support research, and public policy. The workgroup reviewed the literature on Alzheimer's care and support; reviewed how other countries are addressing the issue; and identified public policies needed over the next 10 years to achieve a more ideal care and support system. Results: The workgroup developed and recommended 73 milestones for Goal 2 and 56 milestones for Goal 3. Discussion: To advance the implementation of the U.S. national Alzheimer's plan, the U.S. government should adopt these recommended milestones, or develop similar milestones, to be incorporated into the national plan.
Introduction
Alzheimer's disease and other dementias are progressive, debilitating conditions that affect millions of Americans, their families, and federal and state governments. Total payments for the care of people with Alzheimer's and other dementias was an estimated $226 billion in 2015, of which nearly 70 percent was paid by Medicare and Medicaid [1] . Barring a method of prevention or treatment, total costs of care will grow to an estimated $1 trillion in 2050 [1] . The high costs of caring for Alzheimer's and other dementias make them among the most costly conditions in the United States [2, 3] .
Perhaps even more daunting than the costs of care is the burden on individuals and families. Over time, affected individuals become completely dependent on others. Underscoring this, about 15 million unpaid family members and friends provided over 17 billion hours of unpaid care in 2014 [1] . As more baby boomers reach the age of greater risk of developing Alzheimer's, it can be expected that millions of them will spend their retirement years either living with the disease or caring for someone who has it.
Recognizing the significance of this growing crisis, the U.S. Department of Health and Human Services (HHS), under the auspices of the National Alzheimer's Project Act [4] (NAPA), created the National Plan to Address Alzheimer's Disease. Released in 2012 [5] and updated annually [6] , the National Plan aims to assist individuals and families affected by Alzheimer's and other dementias by advancing research, enhancing care and support, and increasing collaboration across federal, state, and tribal governments.
Among the National Plan's five goals, two goals specifically relate to care and support: goal 2, "Enhance care quality and efficiency" and goal 3, "Expand supports for people living with Alzheimer's disease and their families." Although the federal government has established a series of milestones required to meet the National Plan's first goal on research [7] , which have been reviewed by independent experts [8] , it has yet to establish similar milestones on care and support. Appendix 2 of the most recent iteration of the National Plan [6] lists "implementation milestones"-actions that have been completed or are currently underway by various federal agencies-across all five goals of the National Plan. However, these are a listing of actions that have been completed or are currently underway and are not analogous to the milestones created by the National Institutes of Health (NIH) to indicate what must be accomplished by 2025 to successfully attain the Plan's first goal regarding research on prevention and treatments.
To assist with the establishment of analogous milestones for goals 2 and 3, the Alzheimer's Association convened an expert workgroup to develop recommendations on a comprehensive set of milestones and timelines. The workgroup consisted of experts in the fields of clinical care and long-term services and supports, dementia care and support research, and public policy. In addition, external advisors, including representatives from various federal agencies and experts specializing in the fields of elder justice, dementia care, and public and private health systems, served as peer reviewers on the workgroup's recommendations, providing input and making suggestions for improvement.
This report outlines the workgroup's activities and recommended milestones for adoption by HHS as part of the National Plan. Table 1 summarizes milestones to meet  goal 2; Table 2 summarizes milestones to meet goal 3. Within each table, milestones are listed according to existing strategies in the National Plan. Except for one recommendation under goal 3 and discussed below, the workgroup did not change the existing strategies but focused instead on developing milestones for each of the existing strategies. In the tables, under each of these strategies, milestones are grouped by sections and include a detailed description of each milestone, its success criteria and an estimated timeline to meet those criteria. Although the number of milestones for each goal appears extensive (73 milestones under goal 2 and 56 milestones under goal 3), each set of milestones is comparable in volume to the 86 milestones established to meet goal 1. They are also indicative of the substantial effort that the workgroup believes is necessary to achieve goals 2 and 3.
Key activities
From October to December 2015, the workgroup participated in four phone meetings and one in-person meeting to formulate and review the milestones. In addition, select members of the workgroup also participated in topicspecific calls on select strategies the workgroup felt required further discussion. Each workgroup member also provided input through one-on-one interviews and in written comments on the numerous drafts of the recommendations.
Establishing objectives
Goals 2 and 3, and their strategies, had been previously identified in the National Plan. The workgroup did not seek to change that existing structure or what had been previously identified but instead focused on developing milestones for each of the existing strategies. The workgroup used the milestones established by the NIH for goal 1 as a guide [7] . That effort sets as milestones all steps and activities that need to be undertaken by 2025 to reach the overarching goal. However, unlike for goal 1, the language of goals 2 and 3 is fairly general, and the workgroup believed it needed to begin by more specifically articulating the 2025 "endpoint" in the areas of care and support. Thus, more specific objectives were established. For both goals, the objectives are consistent with the ideal care and support systems for all individuals with chronic conditions. For goal 2, "Enhance care quality and efficiency," the Table 1 Proposed milestones for goal 2
Milestone
Implementation detail Success criteria Strategy 2A: Build a workforce with the skills to provide high-quality care
Milestone section: Build and retain a diverse dementia-capable workforce with the skills and capacity to provide high-quality care
Identify and set targets for dementia-capable workforce needs at the state and county level* Collect data on current dementia-capable workforce capacity and training needs at a state and county level, project growth in workforce demand, and estimate future shortages. Dementiacapable workforce should include primary care physicians, geriatricians, hospitalists, neurologists, psychiatrists, psychologists, nurses, social workers, health care administrators, and related disciplines, including physician assistants, nurse practitioners, direct-care workers, nursing home workers, and home health aides. Collect information on current and projected levels of dementia-capable workforce diversity by location, race, ethnicity, and sexual orientation and set targets to increase representation of each underrepresented group over time. Timeline: Short term
Outline county and state 2025 targets for dementia-capable workforce needs by setting and provider type, published by 2017
Increase dementia-capable workforce through financial incentives and competitive income Create financial incentives (through tuition assistance, loan forgiveness, housing subsidies, and stipends) and ensure competitive income to increase the number of health care providers, including professionals and direct-care workers, who pursue education and training to become dementia capable, particularly those who make a commitment to work in underserved communities or underserved provider settings in otherwise served communities. Timeline: Long term Achieve dementia-capable workforce targets across settings and providers in 80% of states and counties by 2025
Increase dementia-specific technical education for direct-care roles Provide funding for dementia-specific direct-care education for workforce positions that do not require a 4-year college degree for: (1) students pursuing education for direct-care roles and (2) community or technical colleges, high school allied health career or technical programs, and online courses to provide the necessary education. Timeline: Long term Dementia-capable direct-care workforce targets met in 80% of states and counties by 2025
Expand efforts to retain direct-care workforce by building career pathways with supervisory and administrative support Consult with national and state groups already devoted to developing direct-care workforce career pathways and form a coalition of public-private partnerships to develop and implement career pathways that provide career ladders for direct-care workers, offer employers a professional pipeline to aid in job recruitment and retention and have supervisory and administrative commitment, especially in for-profit facilities. Link workforce incentives (financial and not) to tenure in career pathway. Timeline: Long term Formal direct-care career pathway established by 2020; dementiacapable direct-care workforce targets met in 80% of states and counties by 2025
Increase diverse dementia-capable workforce through financial incentives Create financial incentives for health care providers from diverse communities to pursue dementia-specific practice in those communities. Focus efforts on diverse groups, including tribal populations, African Americans, Hispanics, and lesbian, gay,
Incentives in place to increase diversity of the ADRD workforce by 2025
Alzheimer's Association National Plan Care and Support Milestone Workgroup / Alzheimer's & Dementia 12 (2016) 334-369
bisexual, and transgendered (LGBT) individuals, which are underrepresented in the dementia-capable workforce relative to the Alzheimer's disease and related dementias (ADRD) population. Examine whether the loss of state and federal benefits when an individual returns to the workforce creates a barrier to attracting workers from diverse communities. Timeline: Long term Milestone section: Ensure health care providers across settings are skilled and credentialed in dementia-specific care
Create and gain endorsement of national professional dementia-specific training curricula tailored to clinical specialties Create national dementia-specific curricula, incorporating best of existing programs, for higher education, tailored to primary care, geriatrics, hospital care, neurology, psychiatry, psychology, nursing, social work, health care administration, and related disciplines. Provide Centers for Medicare and Medicaid Services (CMS) Direct Graduate Medical Education (DGME) funds only to hospitals that incorporate the national dementia-specific curricula within the broader context of geriatric medicine Tie Medicare Direct Graduate Medical Education (DGME) funds to the implementation of the national professional dementia-specific training curricula, within the broader context of geriatric medicine, for all medical and residency programs focused on primary care, geriatrics, hospital care, neurology, psychiatry, and related disciplines with exceptions granted for non-relevant specialties such as pediatrics. Timeline: Short term/Medium term DGME funds tied to all relevant medical training curricula by 2020; tied to primary care by 2017; tied to geriatrics and hospitalists curricula by 2018; tied to neurology psychiatry and psychology curricula by 2020
Expand dementia specialization in universities Support universities in the development and expansion of dementiaspecific track for residents, physician assistants, nurse practitioners, and psychology students and raise awareness of availability of such programs to promote enrollment. Timeline: Long term .50% of residency, physician assistant, nurse practitioner, and professional psychology programs adopted a dementia-specific medical specialization by 2025
Alzheimer's Association National Plan Care and Support Milestone Workgroup / Alzheimer's & Dementia 12 (2016) 334-369 Educate providers on HIPAA allowances that allow clinician to meet with key family and friend caregivers of persons with ADRD independently Work with professional and trade associations to educate clinicians, hospitalists, and other members of their teams on current HIPAA allowances that allow for providers' discretion in certain circumstances to meet with key family and friend caregivers of persons with ADRD independently without he or she being present, especially as it pertains to topics difficult to discuss in front of the person with ADRD, such as advanced care planning and behavioral management. Leverage-existing HIPAA guidelines to educate clinicians and key family and friend caregivers. Timeline: Short term
Education disseminated through institutes of higher learning, continuing education, and health care professional meetings by 2018
Milestone section: Ensure ADRD self-management education and skill building for persons with ADRD and their families across provider networks Reimburse for ADRD self-management education and skill building across provider networks Provide Medicare reimbursement for social workers, certified counselors, or dementia-qualified health care providers across health systems, to provide ADRD self-management education and skill building for people with ADRD and their key family and friend caregivers, similar to existing Medicare reimbursement for diabetes self-management educators. Milestone section: Outline ADRD-specific guidelines for hospital, acute, palliative, and hospice care
Specify the components of dementia-competent hospital care and encourage adoption Specify guidelines for dementia-competent hospital care, which should include guidelines on assessing a hospitalized patient's cognitive condition at initial sign of impairment, evidence-based strategies for communicating with patients with cognitive impairment, guidance on using protocols to address delirium, and identifying a root cause of behavioral expression and addressing through a person-centered, nonpharmacologic approach. Guidelines should also include discharge guidelines, including identifying a postdischarge arrangement, establishing follow-up appointments before discharge, providing discharge instructions to minimize risk of readmission, and working with patient with ADRD and key family and friend caregivers, where exists, to align on medication management. Disseminate information and partner with universities and health care professional and trade associations to include in hospitalist training and continuing education. Timeline: Medium term Guidelines created, endorsed by key professional, trade, and accreditation associations and disseminated by 2017; Incorporated into 80% of hospitalist education programs and 90% of continuing education credits for hospitalists by 2020;
Collate existing evidence to identify gaps in knowledge, practice, and funding for alternative acute care models for persons with ADRD Collate existing evidence to identify gaps in knowledge, practice, and funding mechanisms for alternative support models that allow persons with ADRD to receive high-quality care for acute episodic illnesses at their residence, including nursing homes, assisted living facilities, or their home, as opposed to in a hospital. Ensure key family and friend caregivers are effectively integrated in acute care models that provide care in the home. Evaluate whether effective international models, such as Hospital at Home, might provide higher quality and more cost-effective care for patients with ADRD. Provide funding to roll out ADRD care and support interventions proven effective and adaptive throughout community settings Scale up effective, pragmatic, and adaptive ADRD care and support interventions in community settings for both persons with ADRD and their key family and friend caregivers, including those that promote statistically sound quality improvement on a populationlevel and system-level, with the goal of providing the most effective interventions to the greatest number of persons with ADRD and their key family and friend caregivers. Create a public-private partnership to initiate a system for identification and consumer review of ADRD qualified physicians Create a public-private partnership to outline criteria for identifying "dementia-qualified" practitioners, which may include some combination of minimum number of ADRD patients in practice; board certification in specialties such as neurology, geriatrics, geriatric psychiatry, or geriatric psychology; minimum ADRD training programs completed for primary care physicians such as the Harvard Dementia Care Program or others. Partnership should provide designation for all practitioners who meet such requirements as "dementia-qualified" and create a system to disseminate that list to the public and request consumer reviews for these physicians, enabling consumer choice based on quality. Partnership should align on objective rating criteria for reviews and ensure quality controls in place to verify reviewer authenticity. services that could increase the care quality and reduce the cost of their health care resource utilization. Make recommendations to reduce those barriers to access. Timeline: Short term/Medium term Provide funding and create triggers to encourage greater participation in advanced care, legal, and financial planning for persons with ADRD Provide funding to hospitals/clinics to have nurse practitioners, social workers, certified counselors, or other nonphysician facilitators help families complete advance care directives as part of a care plan on ADRD diagnosis (Strategy 2C). Additionally, identify specific "trigger" points, such as when one is admitted to the hospital, fills out a life insurance policy, or signs up for social security to encourage comprehensive advanced care, legal, and financial planning, enabling persons with ADRD to make vital decisions while still cognitively aware. Provide guidance on how and when to address the conversation around limiting access to equipment that could endanger public safety as a result of cognitive impairment, including motor vehicles, guns, and others. Build a coalition of public, private, and nonprofit entities to ensure "trigger" points for advanced care directives using standardized forms (strategy 2F) are implemented into the appropriate health, legal, and financial systems to be completed by persons with ADRD and their key family and friend caregivers before a time of crisis. Timeline: Long term
Funding provided for facilitators of advanced care planning by 2018; Trigger points identified by 2019; advanced care, legal, and financial planning incorporated at trigger points by 2022; .90% of persons with ADRD completing advanced care directives at or before trigger points by 2025
Milestone section: Increase access to financial supports to pay for future care needs Incentivize employers to offer long-term care (LTC) insurance Incentivize employers to offer LTC insurance policies as part of common benefit packages, alongside health, life, dental, and others, to encourage increased uptake by the workforce. Timeline: Long term
Incentives in place by 2024
Define standards and restructure LTC insurance to enhance affordability and coverage Define standards for LTC insurance, including eliminating exclusions for persons with ADRD, introducing inflation protection, ensuring policy can be used at most facilities, and implementing a federal "backstop" for coverage of individuals with ADRD to constrain the risks being insured, enhancing the affordability, coverage, and reliability for people in need.
Restructure LTC insurance to meet guidelines. Timeline: Long term
Standards defined and LTC insurance restructured by 2025
Explore the feasibility of new regulation that allows life insurance policies to convert to LTC insurance** Partner with LTC insurance commissioners to explore the feasibility of new insurance regulations that allow an individual to convert life insurance to LTC insurance to fund long-term services and supports. Identify quality measures for APS and create a system to collect data and track performance against those measures Identify quality standards and measures for APS, such as average response times to calls, in working with persons with ADRD and their key family and friend caregivers to measure facility and worker performance. Create a system to collect data on performance against quality measures and track progress over time. Use child protective service system as a model. Timeline: Short term Quality standards identified and data collection system created by 2018
Provide federal funding to APS to help facilities ramp up to meet quality measures and as incentives to maintain high-quality services Provide increased overall federal funding to all APS facilities to help them ramp up service delivery to improve on identified quality measures over a 3-year horizon. After 3-year ramp up horizon, continue funding for facilities who meet minimum quality standards to incentivize high-quality services. Ensure cross-state adult guardianship framework* Ensure Uniform Adult Guardianship and Protective Proceedings Jurisdiction Act is passed in all 50 states to ensure a framework is in place for courts in different states to communicate about adult guardianship cases and thus make the resolution of multistate jurisdictional issues easier for family members, and in many cases, alleviate the need for re-adjudication of guardianship issues.
Timeline: Short term
In place in all 50 states by 2019
Create a public-private partnership to increase access and raise awareness of legal services equipped to counsel persons with ADRD and their key family and friend caregivers Create a public-private partnership that includes key professional organizations representing attorneys, such as the American Bar Association, clinician professional organizations, and large universities to increase access and raise awareness of legal services in the community, including elder law clinics, to persons with ADRD and their key family and friend caregivers. 
Building on existing efforts
The workgroup acknowledged ongoing efforts of key federal agencies toward the established goals and strategies in the National Plan. In addition to noting areas where material progress had been made-such as the dementiaspecific primary care curriculum under development by the Health Resources and Services Administration; the Centers for Disease Control and Prevention's (CDC) Healthy People 2020 dementia objectives; the Administration on Community Living's work in support of caregivers, including the Alzheimer's Disease Supportive Services Program and the creation of alzheimers.gov; and the Centers for Medicare and Medicaid Services' (CMS) efforts to support the detection of cognitive impairment during the Medicare Annual Wellness Visit-the workgroup sought to incorporate and expand on these efforts in its recommendations. In addition, the workgroup noted that in areas of common subject matter, the recommended milestones are consistent with the CMS Quality Strategy report [9] .
Defining terms
The workgroup noted different interpretations for various terms used in NAPA, the National Plan and general Alzheimer's lexicon and sought to establish terms that were more explicit and inclusive. For example, although the workgroup acknowledged that NAPA and the National Plan explicitly use the term "Alzheimer's disease" to encompass all forms of dementia, the workgroup chose to adopt "Alzheimer's disease and related dementias," abbreviated ADRD, throughout the milestones.
Similarly, the workgroup believed that terms like "families" or "family caregivers" were not inclusive of unpaid assistance provided by individuals who are unrelated to their care recipients. Therefore, as the workgroup believed that these unrelated, unpaid caregivers were nevertheless meant to be included as beneficiaries of the supports referred to in the National Plan-and often provide crucial support-the workgroup chose to adopt the term, "key family and friend caregivers." Although paid caregivers are not included in this designation, milestones addressing paid caregivers are included in the strategy on the workforce, consistent with the structure and approach of the National Plan. Furthermore, while using the term "caregivers" is consistent with the widely used lexicon, particularly in professional circles, the workgroup recognized that the term may not be similarly used among those family members and friends who are actually providing care.
Because the workgroup did not seek to amend the already existing strategies, the recommended use of "ADRD" and "key family and friend caregivers" is not reflected in the strategies in the Tables. However, the workgroup recommended incorporating these amended terms throughout the National Plan. For example, strategy 2C "Educate and support people with Alzheimer's disease and their families on diagnosis" could be broadened to also include ADRD and key family and friend caregivers. Likewise, key family and friend caregivers could be used in place of "family caregivers" in strategy 3B. Similar changes could be made to strategies 2E, 2F, 2G, 2H, 3C, 3D, and 3E.
The workgroup also spent time discussing the term "dementia-capable"-what it meant and how it differed from similar sounding terms such as "dementia-friendly." Within strategy 2A, the workgroup agreed the term "dementia-capable" should be used to describe the target skill level of the workforce caring for people with ADRD, but recognized that the term is multidimensional and that the agreed-on definition may be a limitation of this work.
The workgroup struggled to come to consensus on what populations were "disproportionately affected" by Alzheimer's disease and related dementias. Ultimately, the workgroup adopted the National Plan's definition, which identified three specific populations: persons with youngeronset dementia, racial and ethnic minorities, and persons with Down syndrome and other pre-existing intellectual disabilities. However, the workgroup believed that other specific subpopulations are underserved and present unique challenges beyond the challenges of ADRD in general. As noted in various milestones (e.g. milestones under strategies 2E, 2H, 3B, 3D, 3E, and 3F) of particular concern are individuals with ADRD who live alone and/or in rural areas. Viable service options and research and development on innovative service-delivery systems are needed for these populations.
The workgroup experienced similar challenges when interpreting what comprised an "accurate" diagnosis, as noted in strategy 2B, "Ensure timely and accurate diagnosis." The workgroup agreed the word "accurate" was imprecise, owing to current limitations of diagnostic tests and cognitive assessment for ADRD and suggested replacing it with the term "appropriate." It is possible, however, that by 2025-the period covered by NAPA and these recommended milestones-technological and other advancements could occur that would add more precision to the term "accurate."
Recognizing the roles of federal and state governments
As noted in the National Plan, the workgroup acknowledged that achievement of an ideal system of care and support by 2025 will require coordination across federal, state, and local entities-and, in some cases, by both health care and non-health care agencies. As a result, the workgroup recognized that certain of its recommended milestones would require efforts by both federal and state governments or would need to be largely addressed and accomplished at the state level. In Tables 1 and 2 , milestones are assumed to be the responsibility of the federal government unless denoted with an asterisk (*), indicating primarily state-level initiatives or two asterisks (**), indicating joint federal-led and state-led policies.
Estimating timelines
The workgroup provided guidance on the estimated amount of time required to achieve each milestone's success criteria. Milestones that should be expected to reach their success criteria between today and 2019 are designated as "short term;" between 2020 and 2023 as "medium term;" and between 2024 and 2025 as "long term." The workgroup recognized that select milestones, such as those that require changes in regulations or statutes, may take longer to enact than others. However, with the rapid growth of an aging population, the workgroup stressed the urgent need to move forward with milestone implementation. In other words, the timeline designation should be interpreted as the recommended date of achievement, not the timeframe in which to begin addressing the milestones; the work related to many milestones designated "long term" must nonetheless begin immediately. Also, the timeline designation is not meant by the workgroup and should not be interpreted as reflecting relative importance of the milestones.
Furthermore, the workgroup noted that not all the milestones are linear in nature. Although it is tempting to think of milestones in the abstract as a sequential series of actions or intermediate targets on the way toward meeting an overarching goal-one action to follow another-that is neither possible nor always advisable in this case. Some of the recommended milestones do naturally follow other milestones. For example, ensuring that quality care standards are adopted and incorporated in practice settings necessarily first requires that quality care standards be established. But, as with the milestones established by the NIH for goal 1, not all steps that need to be taken necessarily need to follow specific earlier actions.
Numerous milestones can and need to be addressed simultaneously, and some milestones will naturally take longer to achieve given that they involve more complicated legislative and regulatory processes. Tables 1 and 2 contain all the recommended milestones for goals 2 and 3 of the National Plan, including detail on the implementation of each milestone, most of which is self-explanatory. For a few strategies and milestones, however, the workgroup believed that it was necessary to make some specific clarifying comments.
Discussion of specific milestones

Strategy 2B on diagnosis
During its discussion, the workgroup deliberated what was the best way to "ensure timely and accurate diagnosis" as noted by strategy 2B. Rather than focus on milestones that solely supported diagnosis of ADRD, the workgroup felt it was important to also consider milestones that would support the identification and disclosure of cognitive change over time. Consequently, the workgroup concluded that clinicians should assess the cognitive and functional skills of individuals at risk for ADRD and disclose clinically consequential cognitive impairment-that is, cognitive impairment that is accompanied by deficits in an individual's activities of daily living or instrumental activities of daily living. Furthermore, clinicians should ensure that diagnosed individuals and their key family and friend caregivers, where they exist, are aware of any ADRD diagnosis. The workgroup clarified that it is not the aim of the diagnosis-related milestone recommendations, given the current state of the science, to call for, at this time, the use of biomarkers for all individuals at risk of cognitive impairment.
Strategy 2D on guidelines
The milestones in Strategy 2D include the development of high-quality guidelines and measures on the clinical care of individuals with dementia across care settings. Although mentioned within the recommendations themselves, the workgroup wanted to underscore that all such quality measures should be explicitly tied to both processes and clinical person-centered and family-centered outcomes.
Strategy 2E regarding research on care and support practices
The workgroup spent considerable time discussing milestones to support research on new models of care for people with ADRD and their key family and friend caregivers (strategy 2E). The workgroup strongly supported additional research. But, although the workgroup endorsed the "gold standard" of randomized-controlled trials (RCTs) in studies of discrete biochemical interventions (such as medications), it also noted that evaluating certain care and support models in RCTs is not always feasible and may be a poor method of learning from and monitoring complex, real-world system change. Methods drawn from management science and epidemiology will often be more appropriate and should be prioritized and funded in those settings. There was also consensus on the need to test innovations and use research methods that promote quality care for all affected by ADRD at a population level, not just for the individual with ADRD. It should become possible to compare quality over time in a particular city or county and to compare across geographical areas.
During discussion on the success criteria, the workgroup highlighted that some studies may address more than one milestone, such as translational studies that also evaluate cost effectiveness of a particular intervention, reducing the potential number of overall studies needed. The workgroup also noted that a particular care or support intervention may require multiple replications in separate studies to be considered evidence based. The workgroup further noted that variations in treatment and support across populations of interest would be expected to affect many measures of quality, either directly or by altering the proportion of persons living at different stages of ADRD. Methods should be developed to monitor and account for these variations.
Strategy 3D on safety, dignity, and inclusive communities
The workgroup made several observations as it developed milestones for Strategy 3D, "Maintain the dignity, safety, and rights of people with Alzheimer's disease." First, the workgroup felt the existing strategy was far reaching and encompassed too many topics under the rubric of a single strategy. The workgroup also noted that, although it is implicit in some of the recommended milestones on safety (such as recommendations on emergency preparedness and transportation), the idea of creating and expanding communities inclusive of people with ADRD appeared to be missing and did not naturally fall under any specific existing strategy. As a result, the workgroup recommended revising strategy 3D to focus on the dignity and rights of people with ADRD and recommended a new strategy, 3F, "Identify and support efforts to build communities that are more inclusive and safe for persons with ADRD." The workgroup agreed the term "inclusive" was meant to describe the aspiration of communities effectively adapting to the needs of persons with ADRD, yet recognized the lack of an agreedupon consensus of what such an effort entails, thus potentially limiting the work.
Within the realm of dignity and rights for the ADRD population, the workgroup also noted the inherent ambiguity of safety and risk assessments for persons with ADRD. The workgroup suggested an overarching commitment to ensure reasonable autonomy for persons with ADRD, recognizing that bearing responsibility for decision making differs by decision. For example, the choice of what clothing to wear could be respected for many persons with cognitive impairment who could not otherwise bear the responsibility for deciding whether to have an invasive surgery.
Conclusion
Although much work needs to be done to achieve goals 2 and 3 of the National Plan by 2025, the workgroup believed that the recommended milestones included in Tables 1 and 2 are a significant step toward changing how care and supports are provided for people affected by ADRD, their families, and their key family and friend caregivers.
RESEARCH IN CONTEXT
1. Systematic review: Pubmed and other searches were conducted to identify best practices in the care of individuals with Alzheimer's and the support of unpaid caregivers. Published state Alzheimer's plans and dementia plans from other countries were mined for policy ideas.
2. Interpretation: For the first time, a set of comprehensive milestones have been identified to achieve goals 2 (care) and 3 (support) of the U.S. national Alzheimer's plan-providing a comprehensive listing of what is needed by 2025 to ensure a high-quality care and support system for people with Alzheimer's and their families.
3. Future directions: The milestones could be improved with the development of a consensus in the field as to what is meant by "dementia-capable" and what specifically is needed for communities to be "inclusive" of individuals with dementia. The milestones could be strengthened with further research that results in identification of ways to prevent Alzheimer's and of biomarkers that aid in diagnosis.
